Publications
1,220
Citations
31,487
Est. group size
~6
Recurring co-author estimate
Active years
41
Publishing since 1986
Angelo D'Alessandro studies the chemistry of metabolism in blood and disease, using techniques like metabolomics (the large-scale measurement of small molecules in cells) and mass spectrometry. A major focus is how red blood cells function and change during storage for transfusion, along with how metabolic pathways such as tryptophan breakdown relate to cancer behavior. Recent work examines blocking tryptophan catabolism to reduce the aggressiveness of triple-negative breast cancer.
Publication activity grew steadily from 2017 and rose sharply around 2023, remaining at a high level in recent years.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Supplementary Figure S4 from Blocking Tryptophan Catabolism Reduces Triple-Negative Breast Cancer Invasive Capacity
2026
- Supplementary Figure S8 from Blocking Tryptophan Catabolism Reduces Triple-Negative Breast Cancer Invasive Capacity
2026
- Supplementary Table S7 from Blocking Tryptophan Catabolism Reduces Triple-Negative Breast Cancer Invasive Capacity
2026
- Supplementary Figure S1 from Blocking Tryptophan Catabolism Reduces Triple-Negative Breast Cancer Invasive Capacity
2026
- Supplementary Table S3 from Blocking Tryptophan Catabolism Reduces Triple-Negative Breast Cancer Invasive Capacity
2026
- Supplementary Table S10 from Blocking Tryptophan Catabolism Reduces Triple-Negative Breast Cancer Invasive Capacity
2026
- Supplementary Figure S10 from Blocking Tryptophan Catabolism Reduces Triple-Negative Breast Cancer Invasive Capacity
2026
- Supplementary Figure S11 from Blocking Tryptophan Catabolism Reduces Triple-Negative Breast Cancer Invasive Capacity
2026
- Supplementary Table S9 from Blocking Tryptophan Catabolism Reduces Triple-Negative Breast Cancer Invasive Capacity
2026
- Supplementary Table S5 from Blocking Tryptophan Catabolism Reduces Triple-Negative Breast Cancer Invasive Capacity
2026
- Supplementary Table S4 from Blocking Tryptophan Catabolism Reduces Triple-Negative Breast Cancer Invasive Capacity
2026
- Supplementary Table S2 from Blocking Tryptophan Catabolism Reduces Triple-Negative Breast Cancer Invasive Capacity
2026
- Supplementary Table S8 from Blocking Tryptophan Catabolism Reduces Triple-Negative Breast Cancer Invasive Capacity
2026
- Supplementary Figure S7 from Blocking Tryptophan Catabolism Reduces Triple-Negative Breast Cancer Invasive Capacity
2026
- Supplementary Figure S3 from Blocking Tryptophan Catabolism Reduces Triple-Negative Breast Cancer Invasive Capacity
2026
- Blood×92
- bioRxiv (Cold Spring Harbor Laboratory)×61
- Transfusion×41
- PubMed×17
- Journal of Proteome Research×16
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile